These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 8504279

  • 1. N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate: synthesis and potential utility for the radioiodination of monoclonal antibodies.
    Garg PK, Garg S, Zalutsky MR.
    Nucl Med Biol; 1993 May; 20(4):379-87. PubMed ID: 8504279
    [Abstract] [Full Text] [Related]

  • 2. Radiohalogenation of a monoclonal antibody using an N-succinimidyl 3-(tri-n-butylstannyl)benzoate intermediate.
    Zalutsky MR, Narula AS.
    Cancer Res; 1988 Mar 15; 48(6):1446-50. PubMed ID: 3345515
    [Abstract] [Full Text] [Related]

  • 3. Radioiodination of antibodies via N-succinimidyl 2,4-dimethoxy-3-(trialkylstannyl)benzoates.
    Vaidyanathan G, Zalutsky MR.
    Bioconjug Chem; 1990 Mar 15; 1(6):387-93. PubMed ID: 2099187
    [Abstract] [Full Text] [Related]

  • 4. Enhanced tumor localization and in vivo stability of a monoclonal antibody radioiodinated using N-succinimidyl 3-(tri-n-butylstannyl)benzoate.
    Zalutsky MR, Noska MA, Colapinto EV, Garg PK, Bigner DD.
    Cancer Res; 1989 Oct 15; 49(20):5543-9. PubMed ID: 2477144
    [Abstract] [Full Text] [Related]

  • 5. Radioimmunotherapy of breast cancer xenografts with monoclonal antibody ICR12 against c-erbB2 p185: comparison of iodogen and N-succinimidyl 4-methyl-3-(tri-n-butylstannyl)benzoate radioiodination methods.
    Smellie WJ, Dean CJ, Sacks NP, Zalutsky MR, Garg PK, Carnochan P, Eccles SA.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5842s-5846s. PubMed ID: 7493357
    [Abstract] [Full Text] [Related]

  • 6. A method for the radiohalogenation of proteins resulting in decreased thyroid uptake of radioiodine.
    Zalutsky MR, Narula AS.
    Int J Rad Appl Instrum A; 1987 Dec 01; 38(12):1051-5. PubMed ID: 2828275
    [Abstract] [Full Text] [Related]

  • 7. Optimization of radioiodination and biotinylation of monoclonal antibody chimeric BR96: an indirect labeling using N-succinimidyl-3-(tri-n-butylstannyl)benzoate conjugate.
    Chen J, Strand SE, Sjögren HO.
    Cancer Biother Radiopharm; 1996 Jun 01; 11(3):217-26. PubMed ID: 10851540
    [Abstract] [Full Text] [Related]

  • 8. Synthesis of radioiodinated N-succinimidyl iodobenzoate: optimization for use in antibody labelling.
    Garg PK, Archer GE, Bigner DD, Zalutsky MR.
    Int J Rad Appl Instrum A; 1989 Jun 01; 40(6):485-90. PubMed ID: 2551846
    [Abstract] [Full Text] [Related]

  • 9. Maleimidoethyl 3-(tri-n-butylstannyl)hippurate: a useful radioiodination reagent for protein radiopharmaceuticals to enhance target selective radioactivity localization.
    Arano Y, Wakisaka K, Ohmomo Y, Uezono T, Mukai T, Motonari H, Shiono H, Sakahara H, Konishi J, Tanaka C.
    J Med Chem; 1994 Aug 05; 37(16):2609-18. PubMed ID: 8057303
    [Abstract] [Full Text] [Related]

  • 10. N-succinimidyl 5-(trialkylstannyl)-3-pyridinecarboxylates: a new class of reagents for protein radioiodination.
    Garg S, Garg PK, Zalutsky MR.
    Bioconjug Chem; 1991 Aug 05; 2(1):50-6. PubMed ID: 1878411
    [Abstract] [Full Text] [Related]

  • 11. Monoclonal antibody F(ab')2 fragment labeled with N-succinimidyl 2,4-dimethoxy-3-halobenzoates: in vivo comparison of iodinated and astatinated fragments.
    Vaidyanathan G, Affleck D, Zalutsky MR.
    Nucl Med Biol; 1994 Jan 05; 21(1):105-10. PubMed ID: 9234271
    [Abstract] [Full Text] [Related]

  • 12. Improved therapeutic efficacy of a monoclonal antibody radioiodinated using N-succinimidyl-3-(tri-n-butylstannyl)benzoate.
    Schuster JM, Garg PK, Bigner DD, Zalutsky MR.
    Cancer Res; 1991 Aug 15; 51(16):4164-9. PubMed ID: 1714341
    [Abstract] [Full Text] [Related]

  • 13. Labeling proteins with fluorine-18 using N-succinimidyl 4-[18F]fluorobenzoate.
    Vaidyanathan G, Zalutsky MR.
    Int J Rad Appl Instrum B; 1992 Apr 15; 19(3):275-81. PubMed ID: 1629016
    [Abstract] [Full Text] [Related]

  • 14. Astatine-211 labeling of an antimelanoma antibody and its Fab fragment using N-succinimidyl p-astatobenzoate: comparisons in vivo with the p-[125I]iodobenzoyl conjugate.
    Hadley SW, Wilbur DS, Gray MA, Atcher RW.
    Bioconjug Chem; 1991 Apr 15; 2(3):171-9. PubMed ID: 1932216
    [Abstract] [Full Text] [Related]

  • 15. Preparation of N-succinimidyl 3-[*I]iodobenzoate: an agent for the indirect radioiodination of proteins.
    Vaidyanathan G, Zalutsky MR.
    Nat Protoc; 2006 Apr 15; 1(2):707-13. PubMed ID: 17406300
    [Abstract] [Full Text] [Related]

  • 16. Method for radioiodination of proteins using N-succinimidyl 3-hydroxy-4-iodobenzoate.
    Vaidyanathan G, Affleck DJ, Zalutsky MR.
    Bioconjug Chem; 1997 Apr 15; 8(5):724-9. PubMed ID: 9327137
    [Abstract] [Full Text] [Related]

  • 17. Radioiodination of proteins using N-succinimidyl 4-hydroxy-3-iodobenzoate.
    Vaidyanathan G, Affleck DJ, Zalutsky MR.
    Bioconjug Chem; 1993 Apr 15; 4(1):78-84. PubMed ID: 8431515
    [Abstract] [Full Text] [Related]

  • 18. Catabolism of radioiodinated murine monoclonal antibody F(ab')2 fragment labeled using N-succinimidyl 3-iodobenzoate and Iodogen methods.
    Garg PK, Alston KL, Zalutsky MR.
    Bioconjug Chem; 1995 Apr 15; 6(4):493-501. PubMed ID: 7578370
    [Abstract] [Full Text] [Related]

  • 19. Labeling proteins using aryl iodide acylation agents: influence of meta vs para substitution on in vivo stability.
    Garg PK, Slade SK, Harrison CL, Zalutsky MR.
    Int J Rad Appl Instrum B; 1989 Apr 15; 16(7):669-73. PubMed ID: 2613522
    [Abstract] [Full Text] [Related]

  • 20. Astatination of proteins using an N-succinimidyl tri-n-butylstannyl benzoate intermediate.
    Zalutsky MR, Narula AS.
    Int J Rad Appl Instrum A; 1988 Apr 15; 39(3):227-32. PubMed ID: 2836342
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.